NCT06224803View on ClinicalTrials.gov

Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

July 21, 2021

Study Completion Date

January 18, 2022

Conditions
Type II Diabetes
Interventions
DIETARY_SUPPLEMENT

Compound plant extracts

Total supplement including bitter melon (Momordica charantia) fruit extract, celery (Apium graveolens) seed extract, baker's yeast (Saccharomyces cerevisiae) cell wall extract, acerola (Malpighia emarginata) fruit extract, grape (Vitis vinifera) seed extract, green tea leaf extract, and hydrolyzed soy protein powder.

DIETARY_SUPPLEMENT

Indigestible dextrin

Indigestible dextrin as placebo intervention

Trial Locations (1)

221416

Global Preventive Medicine Biotech Co., Ltd., New Taipei City

All Listed Sponsors
lead

Global Preventive Medicine Biotech Co., Ltd.

INDUSTRY

NCT06224803 - Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes | Biotech Hunter | Biotech Hunter